Filing Details
- Accession Number:
- 0001209191-15-074442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-06 20:21:37
- Reporting Period:
- 2015-10-02
- Filing Date:
- 2015-10-06
- Accepted Time:
- 2015-10-06 20:21:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1272354 | Ron Cohen | 420 Saw Mill River Road Ardsley NY 10502 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-02 | 8,811 | $6.00 | 421,211 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-10-02 | 70,358 | $5.85 | 491,569 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-10-02 | 500 | $8.50 | 492,069 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-10-02 | 54,421 | $15.49 | 546,490 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-02 | 134,090 | $28.01 | 412,400 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-10-05 | 910 | $15.49 | 413,310 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-10-05 | 910 | $30.10 | 412,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-10-02 | 8,811 | $0.00 | 8,811 | $6.00 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-10-02 | 70,358 | $0.00 | 70,358 | $5.85 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-10-02 | 500 | $0.00 | 500 | $8.50 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-10-02 | 54,421 | $0.00 | 54,421 | $15.49 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-10-05 | 910 | $0.00 | 910 | $15.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,005 | 2016-02-15 | No | 4 | M | Direct | |
14,642 | 2016-03-17 | No | 4 | M | Direct | |
0 | 2016-09-25 | No | 4 | M | Direct | |
51,673 | 2016-12-21 | No | 4 | M | Direct | |
50,763 | 2016-12-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 100,000 | Indirect | Beneficial Ownership in Trust |
Footnotes
- Exercises and sales pursuant to a 10b5-1 plan. All of the exercised options were scheduled to expire in 2016 on the expiration dates reported within Table II unless exercised. The reporting person sold the shares resulting from the option exercises with the intent to use the proceeds from those sales primarily to cover the exercise prices of the exercised options as well as to fund tax obligations resulting from the reported transactions and other transactions relating to issuer common stock awards granted to the reporting person.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.00 to $28.14 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- These shares were previously reported as directly beneficially owned by the reporting person. On May 28, 2015, the reporting person contributed these shares to a grantor retained annuity trust established by the reporting person. The reporting person is the sole trustee of the grantor retained annuity trust.
- The shares subject to these options vested in installments and were fully vested on 2/15/2010.
- The shares subject to these options vested in installments and were fully vested on 11/10/2010.
- The shares subject to these options vested in installments and were fully vested on 9/25/2010.
- The shares subject to these options vested in installments and were fully vested on 1/1/2011.